Bet_Noire
Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) rose 3% in post-market trading Thursday on news the company had received FDA approval for its non-opioid pain reliever Journavx, also known as suzetrigine.
The agency approved Journavx 50 milligram oral tablets for the treatment